Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Nieuwe vragen voor aios-toetsen
nov 2024 | Bewegingsstoornissen, Epilepsie, Neuro-musculair